Ken Rankin

Articles by Ken Rankin

Surgeon General Report Blasts Rx Drug Importing Practices

ByKen Rankin

March 1st 2005

Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDA

ByKen Rankin

March 1st 2005

Early-Month Rx Fatalities Linked to Overworked Pharmacists

ByKen Rankin

March 1st 2005

Feds Report Rx Expenditures Rose More Slowly in 2004

ByKen Rankin

March 1st 2005

Drug Chains Caution Against OTC Pseudoephedrine Curbs

ByKen Rankin

February 1st 2005

Consumer Reports' Rx Reviews Stir Industry-wide Controversy

ByKen Rankin

February 1st 2005

Medicare Rx Help Line Is Less Than Helpful, GAO Says

ByKen Rankin

February 1st 2005

Congress Debates National Rx Monitoring System

ByKen Rankin

February 1st 2005

Survey Finds Most Chain Drug Execs Wary of Rx Imports

ByKen Rankin

February 1st 2005

Louisiana Seeks to Cut Medicaid Spending with Buying Pool

ByKen Rankin

February 1st 2005

Regulators Plan New "Electronic Pedigree" to Track Drug Packages

ByKen Rankin

February 1st 2005

FDA Moves to Strengthen Postmarketing Rx Safety

ByKen Rankin

January 1st 2005

Interest in Canadian Rx Imports Is Turning Sour

ByKen Rankin

January 1st 2005

APhA Responds to U.S. News' Suggestion for Rx Price Shopping

ByKen Rankin

January 1st 2005

APhA Proposes New "Pharmacy Care OTC" Category of Drugs

ByKen Rankin

January 1st 2005

Rx Price Disclosure "Model Law" Draws Pharmacy's Fire

ByKen Rankin

January 1st 2005

FDA Will Fight Rx Counterfeiting with RFID Packaging

ByKen Rankin

January 1st 2005

Pharmacy's "Usual and Customary" Rx Prices Rise Faster for Branded Drugs

ByKen Rankin

December 1st 2004

Independent Pharmacy Rx Sales and Profits Are Up

ByKen Rankin

December 1st 2004

Chains Seek Clarity in Medicare Rx Drug Rules

ByKen Rankin

December 1st 2004

Electronic Rx-Monitoring Bill Will Reach Congress in 2005

ByKen Rankin

December 1st 2004

List of "Safe" Canadian Pharmacies Stirs New Controversy

ByKen Rankin

December 1st 2004

Study Shows Pharmacists Can Impact Men's Health

ByKen Rankin

December 1st 2004

Save Flu Vaccine for At-Risk Patients, APhA tells Pharmacists

ByKen Rankin

December 1st 2004

Senate Debates New Legislation to Curb Costly Medication Errors

ByKen Rankin

November 1st 2004

Rx Drug Abuse Is on the Increase, HHS Reports

ByKen Rankin

November 1st 2004

Medicare Chief Pushes Generics as Solution to High Rx Prices

ByKen Rankin

November 1st 2004

Pharmacy Boards Move to Accredit Drug Wholesalers

ByKen Rankin

November 1st 2004

California's Anti-PBM Legislation Draws Fire from FTC Staffers

ByKen Rankin

November 1st 2004

Ken Rankin

Articles by Ken Rankin

Surgeon General Report Blasts Rx Drug Importing Practices

Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDA

Early-Month Rx Fatalities Linked to Overworked Pharmacists

Feds Report Rx Expenditures Rose More Slowly in 2004

Drug Chains Caution Against OTC Pseudoephedrine Curbs

Consumer Reports' Rx Reviews Stir Industry-wide Controversy

Medicare Rx Help Line Is Less Than Helpful, GAO Says

Congress Debates National Rx Monitoring System

Survey Finds Most Chain Drug Execs Wary of Rx Imports

Louisiana Seeks to Cut Medicaid Spending with Buying Pool

Regulators Plan New "Electronic Pedigree" to Track Drug Packages

FDA Moves to Strengthen Postmarketing Rx Safety

Interest in Canadian Rx Imports Is Turning Sour

APhA Responds to U.S. News' Suggestion for Rx Price Shopping

APhA Proposes New "Pharmacy Care OTC" Category of Drugs

Rx Price Disclosure "Model Law" Draws Pharmacy's Fire

FDA Will Fight Rx Counterfeiting with RFID Packaging

Pharmacy's "Usual and Customary" Rx Prices Rise Faster for Branded Drugs

Independent Pharmacy Rx Sales and Profits Are Up

Chains Seek Clarity in Medicare Rx Drug Rules

Electronic Rx-Monitoring Bill Will Reach Congress in 2005

List of "Safe" Canadian Pharmacies Stirs New Controversy

Study Shows Pharmacists Can Impact Men's Health

Save Flu Vaccine for At-Risk Patients, APhA tells Pharmacists

Senate Debates New Legislation to Curb Costly Medication Errors

Rx Drug Abuse Is on the Increase, HHS Reports

Medicare Chief Pushes Generics as Solution to High Rx Prices

Pharmacy Boards Move to Accredit Drug Wholesalers

California's Anti-PBM Legislation Draws Fire from FTC Staffers

Medicare Drug Benefit Will Boost Pharmacy Rx Sales, CMS Predicts

Trending on Pharmacy Times

Enlicitide and the New Wave of PCSK9 Inhibitors

GLP-1 Medications and Food: A Pharmacist’s Guide

Overcoming Barriers to Kidney-Protective Therapy

Tiny Parasite, Big Problem: Managing Cyclosporiasis in Pediatric Patients

FDA Approves First Gene Therapy for GSDIa